Sep 09,2024

Highmark expands coverage for RelieVRx device for 4M+ members

Pittsburgh-based Highmark has signed on as AppliedVR's first commercial payer partner, making its flagship VR device for chronic lower back pain a covered treatment for more than 4 million plan members. The program consists of a headset and software guiding patients in pain management exercises. It represents a novel home-based solution for treating chronic pain. The company says RelieVRx serves as a cost-effective, non-pharmacologic adjunctive therapy clinically proven to significantly reduce pain intensity and interference across sociodemographic groups. Highmark’s decision to cover RelieVRx follows a thorough evaluation of AppliedVR’s extensive clinical studies, including a large study with more than 1,000 participants that found RelieVRx can have a clinically meaningful impact on reducing pain intensity and interference. Eligible commercial members aged 18 and older diagnosed with moderate to severe chronic lower back pain can now obtain a prescription for RelieVRx from their healthcare provider without prior authorization. The company says it now works with 200 leading health systems and thousands of healthcare professionals globally, used on more than 60,000 patients.

COLLABORATION PARTNERSHIP

#insurance

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Mar 05,2024

Osara Health announces partnership with Allstate Benefits to offer members cancer care support

Osara Health, a leader in behavior change interventions for cancer, has partnered with Allstate Benefits, a prominent health and supplemental insurer, to provide comprehensive cancer support to members of Allstate's group health benefits program. This partnership marks a first in the U.S. health insurance market, offering Osara’s clinically validated program aimed at improving the quality of life and enabling faster return to work for cancer patients. Osara’s program, developed by oncologists, addresses significant gaps in cancer care, particularly in symptom management, which can reduce healthcare costs and emergency visits. The partnership expands Osara's reach in the U.S., enhancing support for cancer patients while reinforcing Allstate Benefits' commitment to comprehensive member care.

COLLABORATION PARTNERSHIP

#insurance

#virtual care

#coaching

View Analyst & Ambassador Comments
Go to original news
Jul 22,2024

Hinge Health partners with employee benefits company Sun Life

Sun Life has partnered with Hinge Health to offer its members digital access to musculoskeletal (MSK) care, including health coaches, orthopedic surgeons, and physical therapists. Members will also have access to Hinge's pelvic women's health program, the FDA-cleared Enso wearable pain relief device, and in-person physical therapy in certain regions. The services will be available through Sun Life's Health 360 app. This partnership aims to address rising healthcare costs related to MSK conditions.

COLLABORATION PARTNERSHIP

#insurance

#coaching

#connected device

View Analyst & Ambassador Comments
Go to original news
Jun 25,2024 TOP STORY

Guardian and Osara Health announce new cancer support partnership, expanding on Guardian's commitment to inspire well-being®

Guardian Life Insurance Company of America has partnered with Osara Health to offer its Cancer Coach program to members with long-term disability insurance who are diagnosed with cancer. This initiative integrates cancer support directly into Guardian's disability claim management, providing comprehensive assistance through a 12-week program. The program includes access to a dedicated health coach, personalized digital education modules, and the Osara Health app, focusing on mental health, nutrition, and overall wellness. With cancer diagnoses rising, Guardian aims to enhance support for affected members, promoting improved physical and mental health outcomes, faster return to work rates, and overall quality of life improvements.

COLLABORATION PARTNERSHIP

#insurance

#coaching

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 04,2024 TOP STORY

OptiMed adds Vida Health as a Preferred Partner, Introducing Innovative Anti-Obesity Medication Management Program

OptiMed Health Partners has named Vida Health as a preferred partner to enhance their cardiometabolic care services, particularly in clinical obesity management. This collaboration will enable OptiMed to integrate Vida Health's comprehensive virtual care, including anti-obesity medication management, diabetes support, and behavior change coaching, for their members. Vida Health will serve as a center of excellence for anti-obesity medications, ensuring that only prescriptions from their qualified professionals are covered under OptiMed's benefits plan.

COLLABORATION PARTNERSHIP

#insurance

#coaching

#virtual care

View Analyst & Ambassador Comments
Go to original news
May 21,2024

DC Medicaid Becomes the First Medicaid Plan to Cover the Nerivio® REN Wearable, a Non-Drug Treatment for Migraine

Theranica, a neuromodulation therapeutics company, announced that DC Medicaid will cover the Nerivio® REN wearable, an FDA-cleared, non-drug treatment for acute and preventive migraine care in individuals aged 12 and older. This wearable device offers a non-invasive, drug-free option for managing migraines, benefiting over 300,000 DC Medicaid members. DC Medicaid is the second federally funded insurance plan, after the VA, to cover Nerivio, setting a precedent for other insurers. Earlier this year, Highmark Inc. and Blue Cross Blue Shield North Dakota also provided coverage for this device. The coverage of Nerivio is expected to provide significant savings for health insurance companies, with studies showing potential annual savings of $10,000 per member.

COLLABORATION PARTNERSHIP

#insurance

#pdt

#connected device

View Analyst & Ambassador Comments
Go to original news
May 07,2024 TOP STORY

Geisinger Health Plan and OncoHealth to provide comprehensive cancer support to members

Geisinger Health Plan (GHP) with OncoHealth will provide supportive cancer care services to GHP’s more than 550,000 members. GHP will implement OncoHealth’s software and services platform, which combines oncology value management services with virtual cancer care to be sure people with cancer get the most appropriate treatment and support throughout the duration of their treatment. Services include 24/7 oncology nursing, mental health, nutrition, and resource navigation. GHP will begin rolling out OncoHealth in May 2024.

COLLABORATION PARTNERSHIP

#insurance

#virtual care

#coaching

View Analyst & Ambassador Comments
Go to original news
Feb 21,2024

Tempus Expanding Access to its Next-Generation Sequencing Tests as an In-Network Provider for Cigna

Tempus, announced that the company has signed an agreement for in-network provider status with Cigna Healthcare for Tempus’ array of molecular profiling tests. The inclusion of Tempus’ assays in Cigna’s in-network coverage is poised to facilitate broader access to precision oncology care. Notably, this may result in reduced out-of-pocket costs for patients undergoing such testing, aligning with the specifics of their individual plans.

COLLABORATION PARTNERSHIP

#insurance

#clinical decision support

View Analyst & Ambassador Comments
Go to original news
Jan 26,2024 TOP STORY

Cognoa unveils Highmark as first commercial payer partner

Cognoa, maker of the first FDA-approved autism diagnostic tool, announced Highmark has signed on as its first commercial payer partner. The tool, Canvas Dx, will now be reimbursed for commercial Highmark members. It aims to enable earlier and more equitable access to diagnosis for children and families without specialists. The tool leverages AI to empower doctors to quickly and accurately diagnose developmental risk without bias, the company claims. Under the Highmark contract, Canvas Dx can be prescribed by any clinician or advanced practitioner. It does not require prior authorization, and, if a parent or physician identifies risk, a doctor can prescribe it at will. Apart from its AI-driven ability to aid in diagnosis, Canvas Dx also features an automatically generated personalized report with a child’s strengths and challenges based on standard criteria known as DSM-5. This helps eliminate the clinician burden of generating a report,. Part of the goal with this milestone for Cognoa is to establish Canvas Dx as the standard of care in the autism space in the coming year, Dennis Wall, Ph.D., autism researcher and founder of Cognoa, said.

COLLABORATION PARTNERSHIP

#insurance

#pdt

View Analyst & Ambassador Comments
Go to original news
Jan 24,2024

Tempus is Now an In-Network Provider for Humana, Expanding Access to its Next-Generation Sequencing Tests

Tempus announced that the company has signed agreements for in-network provider status with Humana Inc. Under the agreement, Humana’s over 13 million members will have improved access to Tempus’ portfolio of molecular profiling tests in accordance with their medical policies, expanding precision oncology care throughout the country. In-network coverage of Tempus’ assays will support broader access to precision cancer care and may lead to lower out-of-pocket costs for patients who receive any such testing in accordance with their individual plan.

COLLABORATION PARTNERSHIP

#insurance

#genomic profiling

View Analyst & Ambassador Comments
Go to original news
Subscribe to INSURANCE